XML 16 R5.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Noncontrolling Interest
Beginning balance (in shares) at Dec. 31, 2023   188,951,643      
Beginning balance at Dec. 31, 2023 $ 158,071 $ 189 $ 1,037,015 $ (880,258) $ 1,125
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (97,007)     (96,944) (63)
Issuance of common stock upon vesting of restricted and performance stock units (in shares)   2,716,762      
Issuance of common stock upon vesting of restricted and performance stock units 2 $ 2      
Forfeitures (in shares)   (2,799)      
Shares withheld related to net restricted stock settlement (in shares)   (69,820)      
Shares withheld related to net restricted stock settlement (350)   (350)    
Equity-based compensation 54,896   54,896    
Repurchase of noncontrolling interest attributable to subsidiary 15       15
Ending balance (in shares) at Sep. 30, 2024   191,595,786      
Ending balance at Sep. 30, 2024 115,627 $ 191 1,091,561 (977,202) 1,077
Beginning balance (in shares) at Jun. 30, 2024   191,236,747      
Beginning balance at Jun. 30, 2024 124,798 $ 191 1,074,303 (950,789) 1,093
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (26,429)     (26,413) (16)
Issuance of common stock upon vesting of restricted and performance stock units (in shares)   359,039      
Equity-based compensation 17,258   17,258    
Ending balance (in shares) at Sep. 30, 2024   191,595,786      
Ending balance at Sep. 30, 2024 $ 115,627 $ 191 1,091,561 (977,202) 1,077
Beginning balance (in shares) at Dec. 31, 2024 191,778,639 191,778,639      
Beginning balance at Dec. 31, 2024 $ 100,955 $ 192 1,107,952 (1,008,293) 1,104
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 10,028     10,282 (254)
Issuance of common stock upon vesting of restricted and performance stock units (in shares)   7,981,928      
Forfeitures (in shares)   (277)      
Equity-based compensation 48,967 $ 8 48,959    
Stock options exercised (in shares)   228,225      
Stock options exercised 2,771   2,771    
Sale of consolidated subsidiary $ (850)       (850)
Ending balance (in shares) at Sep. 30, 2025 199,988,515 199,988,515      
Ending balance at Sep. 30, 2025 $ 161,871 $ 200 1,159,682 (998,011) 0
Beginning balance (in shares) at Jun. 30, 2025   197,958,237      
Beginning balance at Jun. 30, 2025 140,967 $ 198 1,142,509 (1,001,740) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 3,729     3,729  
Issuance of common stock upon vesting of restricted and performance stock units (in shares)   1,925,632      
Equity-based compensation $ 16,227 $ 2 16,225    
Stock options exercised (in shares) 104,646 104,646      
Stock options exercised $ 948   948    
Ending balance (in shares) at Sep. 30, 2025 199,988,515 199,988,515      
Ending balance at Sep. 30, 2025 $ 161,871 $ 200 $ 1,159,682 $ (998,011) $ 0